They mean the insurer default position is to deny, and you must demonstrate medical necessity through the appeals process
In the phase 2 clinical trial (Jastreboff et al., New England Journal of Medicine , 2023), retatrutide was administered as a once-weekly subcutaneous injection, with doses escalated gradually over time a regimen that reflects the trial protocol
No matter what I do (whether I eat grains/fat or not), I keep gaining
For those who see success, weight loss averages 1-3 pounds per week, similar to FDA-approved semaglutide options like Wegovy
If you need instant results or aren't willing to commit to the full 90-day protocol, this isn't the right fit
Board PG, Baker RT, Chelvanayagam G, Jermiin LS